Skip to main content
OpenTrials

Clinical trial condition

Myasthenia Gravis

Explore clinical trials studying Myasthenia Gravis. Study availability and eligibility vary by location and protocol.

264 public trials 97 recruiting studies
Refine in advanced search Browse all conditions

Myasthenia Gravis trial results

Active, not recruiting

Myasthenia Gravis Inebilizumab Trial

NCT04524273

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations
  • Viela Bio Investigative Site - 1015 Orange, California, United States
  • Viela Bio Investigative Site - 1002 New Haven, Connecticut, United States
  • Viela Bio Investigative Center - 1024 Washington D.C., District of Columbia, United States
  • Viela Bio Investigative Site - 1005 Tampa, Florida, United States
View all 104 locations
View Trial Details
Active, not recruiting

Evaluation of PK, PD, Efficacy, Safety, and Immunogenicity of IV Ravulizumab in Pediatric Participants With Generalized Myasthenia Gravis

NCT05644561

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +12 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Chapel Hill, North Carolina, United States
  • Research Site Philadelphia, Pennsylvania, United States
View Trial Details
Active, not recruiting

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

NCT00716066

Conditions
Autoimmune Disease, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +59 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • Swedish Medical Center-First Hill Seattle, Washington, United States
View Trial Details
Completed

A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis

NCT04650854

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0007 50092 Orange, California, United States
  • Mg0007 50099 San Francisco, California, United States
  • Mg0007 50122 Miami, Florida, United States
  • Mg0007 50120 Miami, Florida, United States
View all 69 locations
View Trial Details
Completed

A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

NCT04124965

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0004 50081 Phoenix, Arizona, United States
  • Mg0004 50072 Los Angeles, California, United States
  • Mg0004 50088 Washington D.C., District of Columbia, United States
  • Mg0004 50120 Miami, Florida, United States
View all 43 locations
View Trial Details
Completed

A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

NCT03971422

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0003 50081 Phoenix, Arizona, United States
  • Mg0003 50082 Scottsdale, Arizona, United States
  • Mg0003 50072 Los Angeles, California, United States
  • Mg0003 50092 Orange, California, United States
View all 112 locations
View Trial Details
Completed

Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

NCT04225871

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0011 41 Mobile, Alabama, United States
  • Mg0011 116 Phoenix, Arizona, United States
  • Mg0011 31 Irvine, California, United States
  • MG0011 4 Los Angeles, California, United States
View all 70 locations
View Trial Details
Completed

Disease-Modifying Treatments for Myasthenia Gravis

NCT03490539

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Stanford University Palo Alto, California, United States
  • Unversity of Miami Miami, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Ochsner Clinic Foundation New Orleans, Louisiana, United States
View all 19 locations
View Trial Details

Related conditions